• Info
  • Insider Trading

John A. Orwin - Insider Trading & Ownership

Location
C/O Relypsa, Inc., 700 Saginaw Dr., Redwood City, CA
Summary
The estimated net worth of John A. Orwin is at least $983K dollars as of September 17, 2025. John A. Orwin is the Director of Travere Therapeutics, Inc. and owns shares of Travere Therapeutics, Inc. (TVTX) stock worth about $648K. John A. Orwin is the Director of ANAPTYSBIO, INC and owns shares of ANAPTYSBIO, INC (ANAB) stock worth about $306K. John A. Orwin is the PRESIDENT & CEO, Director of Atreca, Inc. and owns shares of Atreca, Inc. stock worth about $29K.
Signature
/s/ Eric Loumeau, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when John A. Orwin files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of John A. Orwin

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TVTX Travere Therapeutics, Inc. Director $648K May 15, 2025
ANAB ANAPTYSBIO, INC Director $306K Sep 15, 2025
BCEL Atreca, Inc. PRESIDENT & CEO, Director $29K Apr 11, 2024
CRGX CARGO Therapeutics, Inc. Director Aug 19, 2025
SGEN Seagen Inc. Director Dec 14, 2023

Insider Transactions Reported by John A. Orwin:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.